Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IOCYTE AMI-3
2024-514372-40-00Phase 3Completed
- Sponsor
- Faraday Pharmaceuticals
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 13
01
Overview
Phase 3, randomised, double-blind trial in acute ST-segment elevation myocardial infarction (STEMI) comparing FDY-5301 IV with Placebo IV (2 arms). Started Aug 2024; status: completed.
02
Drugs
Sodium iodide
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2024-514372-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514372-40-00.